Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis B
hepatitis B
An update on Tekmira: From Ebola promise to a strong hep B focus
BioPharma Dive
Thu, 05/7/15 - 11:25 am
Tekmira
ebola virus
hepatitis B
U.S. top court rejects hepatitis B drug patent case
Yahoo/Reuters
Mon, 05/4/15 - 09:43 am
Supreme Court
Baraclude
hepatitis B
Bristol-Myers Squibb
Ichor, J&J to collaborate in $85M hep B immunotherapy deal
BioPharma Dive
Wed, 04/15/15 - 08:51 am
Ichor
JNJ
hepatitis B
immunotherapy
Ichor Medical inks $85m drug-device deal with J&J
Mass Device
Mon, 04/13/15 - 10:33 am
Inchor Medical
devices
JNJ
hepatitis B
Janssen Pharmaceuticals
A Decade Old Drug Launch In China With Important Insights Today
Forbes
Wed, 03/18/15 - 10:53 am
China
Baraclude
hepatitis B
Bristol-Myers Squibb
Mylan Launches Generic Hepatitis B Treatment
Drug Discovery and Development
Mon, 01/19/15 - 11:59 am
Mylan Labs
generics
hepatitis B
GSK
Epivir-HBV
FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial
Reuters
Mon, 01/12/15 - 08:42 am
FDA
hepatitis B
Arrowhead Research
clinical trials
Bristol-Myers Squibb Foundation Awards Nine Grants Totaling More than $3.5 Million to Support Care for High-Risk Patients with Hepatitis B and C in China and India
Yahoo
Wed, 12/3/14 - 10:03 am
Bristol-Myers Squibb
India
grants
hepatitis B
hepatitis C
Arrowhead CEO: We feel 'great' about our hepatitis B drug
CNBC
Mon, 11/10/14 - 07:28 pm
Arrowhead Research
hepatitis B
ARC-520
After hep C cure, companies target next big liver disease market
Yahoo/Reuters
Sun, 11/9/14 - 09:46 am
hepatitis B
hepatitis
nonalcoholic steatohepatitis
Gilead
Galmed Pharmaceuticals
Raptor Pharmaceuticals
Conatus Pharmaceuticals
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine
Yahoo
Mon, 10/20/14 - 10:24 am
FDA
Sanofi Pasteur
pediatric hexavalent vaccine
Merck
vaccines
diphtheria
tetanus
pertussis
Hib
hepatitis B
Arrowhead Sinks on Disappointing Hepatitis B Drug Data
TheStreet.com
Wed, 10/8/14 - 10:53 am
Arrowhead Research
hepatitis B
ARC-520
Radiant/CRA Enroll 8,000 for Hepatitis B Vaccine Study
AZ Big Media
Sat, 09/27/14 - 09:51 am
Radiant CRA
Dynavax
vaccines
hepatitis B
Arrowhead Discloses First Human Hepatitis B Therapy Results
TheStreet.com
Wed, 08/13/14 - 08:28 am
hepatitis B
Arrowhead Research
ARC-520
Bristol-Myers hepatitis B drug patent ruled invalid by appeals court
Yahoo/Fly on the Wall
Thu, 06/12/14 - 11:12 am
hepatitis B
Bristol-Myers Squibb
Teva Pharmaceuticals
patents
Oncolytics Biotech reports evaluation of clinical study with REOLYSIN
The Fly on the Wall
Mon, 04/14/14 - 08:26 am
Oncolytics
Reolysin
hepatitis B
hepatitis C
liver cancer
[video]A $1 Trillion Drug Market?
Motley Fool
Tue, 04/8/14 - 10:44 am
Gilead Sciences
Solvadi
hepatitis C
hepatitis B
Arrowhead Surges As Analysts Laud Hepatitis B Drug
Investors.com
Wed, 03/5/14 - 11:49 am
hepatitis B
Arrowhead Research
ARC-520
Arrowhead: A Functional Cure For The Hepatitis B Virus
Seeking Alpha
Wed, 02/19/14 - 12:49 pm
Arrowhead Research
hepatitis B
RNAi
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »